相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
Paula Vainio et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
Kennosuke Karube et al.
BLOOD (2011)
The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?
Martin McLaughlin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
CCI-779 Inhibits Cell-Cycle G2-M Progression and Invasion of Castration-Resistant Prostate Cancer via Attenuation of UBE2C Transcription and mRNA Stability
Hongyan Wang et al.
CANCER RESEARCH (2011)
Proteostasis regulation at the endoplasmic reticulum: a new perturbation site for targeted cancer therapy
Yanfen Liu et al.
CELL RESEARCH (2011)
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
Biswajyoti Sahu et al.
EMBO JOURNAL (2011)
A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma
Myriam Loyo et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Identification of Gene Markers Associated With Aggressive Meningioma by Filtering Across Multiple Sets of Gene Expression Arrays
Jourdan E. Stuart et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress
L. Dong et al.
ONCOGENE (2011)
Expression of targeting protein for Xenopus kinesin-like protein 2 is associated with progression of human malignant astrocytoma
Bin Li et al.
BRAIN RESEARCH (2010)
Biomarkers for predicting the sensitivity of cancer cells to TRAIL-R1 agonistic monoclonal antibody
Shinsuke Araki et al.
CANCER LETTERS (2010)
FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Santosh Gupta et al.
CANCER RESEARCH (2010)
Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma
Reiko Satow et al.
CLINICAL CANCER RESEARCH (2010)
ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
Paolo Kunderfranco et al.
PLOS ONE (2010)
Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis
Manasa Ramakrishna et al.
PLOS ONE (2010)
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
Joshua A. Bauer et al.
BREAST CANCER RESEARCH (2010)
Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System
Humam Kadara et al.
CANCER PREVENTION RESEARCH (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
Steven L. Warner et al.
CLINICAL CANCER RESEARCH (2009)
High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
Kristiina Iljin et al.
CLINICAL CANCER RESEARCH (2009)
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
J. Iqbal et al.
LEUKEMIA (2009)
In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression
Corbin E. Meacham et al.
NATURE GENETICS (2009)
ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
Yang Zong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer
Mariana Brait et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Characterization of TMPRSS2 : ETV5 and SLC45A3 : ETV5 gene fusions in prostate cancer
Beth E. Helgeson et al.
CANCER RESEARCH (2008)
Expression and function of fatty acid amide hydrolase in prostate cancer
Michael P. Endsley et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
C. Sun et al.
ONCOGENE (2008)
Effects of Eg5 knockdown on human prostate cancer xenograft growth and chemosensitivity
Norihiro Hayashi et al.
PROSTATE (2008)
Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus
Wei Li et al.
PROSTATE (2008)
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues
Sami Kilpinen et al.
GENOME BIOLOGY (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Binding of TPX2 to aurora a alters substrate and inhibitor interactions
Kelly Anderson et al.
BIOCHEMISTRY (2007)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer
Karin G. Hermans et al.
CANCER RESEARCH (2006)
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming
Kristiina Iljin et al.
CANCER RESEARCH (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
Claudin proteins in human cancer: Promising new targets for diagnosis and therapy
PJ Morin
CANCER RESEARCH (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells
P Hååg et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells
R Berger et al.
CANCER RESEARCH (2004)
Proteomics of endoplasmic reticulum-golgi intermediate compartment (ERGIC) membranes from brefeldin A-treated HepG2 cells identifies ERGIC-32, a new cycling protein that interacts with human Erv46
L Breuza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Oncogenic action of secreted phospholipase A2 in prostate cancer
P Sved et al.
CANCER RESEARCH (2004)
Improved statistical methods for hit selection in high-throughput screening
C Brideau et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
Expression profiling reveals off-target gene regulation by RNAi
AL Jackson et al.
NATURE BIOTECHNOLOGY (2003)
Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors
MP DeYoung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells
T Segawa et al.
ONCOGENE (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
分享论文
